Brodsky & Smith Investigates Proposed Acquisition of QIAGEN N.V.
Law firm Brodsky & Smith has announced an investigation into the proposed acquisition of QIAGEN N.V. by EQT Private Equity.
Stocks · News reference
Long-Awaited Qiagen Buyout Closes At 15x EBITDA Multiple as Slow Growth Curbs Pricing
Qiagen agrees to a $12 billion all-cash buyout by EQT. Analysts view the valuation discount as warranted given slower growth.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity
Thailand's NGS market is projected to reach $305.21 million by 2036, growing at a 12.7% CAGR from $92.03 million in 2026. Growth is driven by the Genomics Thailand national precision medicine initiative, rising clinical adoption in oncology and rare diseases, expanded reimbursement under the Universal Coverage Scheme, and increasing demand for outsourced sequencing services. Commercial sequencing services and clinical applications in oncology are expected to be the fastest-growing segments.
Barclays Downgrades QIAGEN to Equal Weight
Barclays Capital downgraded QIAGEN N.V. from "Overweight" to "Equal Weight" and reduced its price target for the company's shares from $55 to $53.
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $52
Evercore ISI Adjusts Thermo Fisher Scientific Price Target
Evercore ISI has revised its price target for Thermo Fisher Scientific Inc., lowering it from $720 to $615.
15-year-old wins top award at 2026 Thermo Fisher Scientific Junior Innovators Challenge
A 15-year-old student received the $25,000 top prize in the 2026 Thermo Fisher Scientific Junior Innovators Challenge for developing a low-cost device to monitor airborne bacteria.